The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment: Results From the Cardiovascular Health Study
Abstract
CONTEXT: Mild cognitive impairment (MCI) may be a precursor to dementia, at least in some cases. Dementia and MCI are associated with neuropsychiatric symptoms in clinical samples. Only 2 population-based studies exist of the prevalence of these symptoms in dementia, and none exist for MCI. OBJECTIVE: To estimate the prevalence of neuropsychiatric symptoms in dementia and MCI in a population-based study. DESIGN: Cross-sectional study derived from the Cardiovascular Health Study, a longitudinal cohort study. SETTING AND PARTICIPANTS: A total of 3608 participants were cognitively evaluated using data collected longitudinally over 10 years and additional data collected in 1999-2000 in 4 US counties. Dementia and MCI were classified using clinical criteria and adjudicated by committee review by expert neurologists and psychiatrists. A total of 824 individuals completed the Neuropsychiatric Inventory (NPI); 362 were classified as having dementia, 320 as having MCI; and 142 did not meet criteria for MCI or dementia. MAIN OUTCOME MEASURE: Prevalence of neuropsychiatric symptoms, based on ratings on the NPI in the previous month and from the onset of cognitive symptoms. RESULTS: Of the 682 individuals with dementia or MCI, 43% of MCI participants (n = 138) exhibited neuropsychiatric symptoms in the previous month (29% rated as clinically significant) with depression (20%), apathy (15%), and irritability (15%) being most common. Among the dementia participants, 75% (n = 270) had exhibited a neuropsychiatric symptom in the past month (62% were clinically significant); 55% (n = 199) reported 2 or more and 44% (n = 159) 3 or more disturbances in the past month. In participants with dementia, the most frequent disturbances were apathy (36%), depression (32%), and agitation/aggression (30%). Eighty percent of dementia participants (n = 233) and 50% of MCI participants (n = 139) exhibited at least 1 NPI symptom from the onset of cognitive symptoms. There were no differences in prevalence of neuropsychiatric symptoms between participants with Alzheimer-type dementia and those with other dementias, with the exception of aberrant motor behavior, which was more frequent in Alzheimer-type dementia (5.4% vs 1%; P =.02). CONCLUSIONS: Neuropsychiatric symptoms occur in the majority of persons with dementia over the course of the disease. These are the first population-based estimates for neuropsychiatric symptoms in MCI, indicating a high prevalence associated with this condition as well. These symptoms have serious adverse consequences and should be inquired about and treated as necessary. Study of neuropsychiatric symptoms in the context of dementia may improve our understanding of brain-behavior relationships.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“case-control studies suggest that depressive symptoms are somewhat more common in older people with mild cognitive impairment or dementia compared to those without cognitive impairment”
From Enrichment Effects on Adult Cognitive Development: Can the Functional Capacity of Older Adults Be Preserved and Enhanced? (2008) · cites this paper as Lyketsos et al., 2002
In the citing paper
“As new onset depression in elderly patients can precede memory impairment in AD, these insights might help guide selection of antidepressant treatment in elderly patients. 25”
From Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation (2026) · cites this paper as [25]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
(1987) · PubMed · Cited by 2,657
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Self-citationMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
Telephone Interview for Cognitive Status
Brandt, J., Spencer, M., & Folstein, M. F. (1988) · PsycTESTS Dataset · doi:10.1037/t28542-000 · Cited by 1,504
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
Self-citationA 5-month, randomized, placebo-controlled trial of galantamine in AD
Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P. R., Lilienfeld, S., Ding, C., & the Galantamine USA- Study Group (2000) · Neurology · doi:10.1212/wnl.54.12.2269 · Cited by 915
Cited by
Sorted by citations
Items 401–500 of 1,003
Volunteering Is Associated with Lower Risk of Cognitive Impairment
Infurna, F. J., Okun, M. A., & Grimm, K. J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14398 · Cited by 75
Pharmacological treatment of neuropsychiatric symptoms of dementia
(2006) · Clinical Governance An International Journal · doi:10.1108/cgij.2006.24811cae.008 · Cited by 68
Waller, K. L., Mortensen, E. L., Avlund, K., Osler, M., Fagerlund, B., Lauritzen, M., & Jennum, P. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.01.004 · Cited by 71
Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease
Blass, D. M., Hatanpaa, K. J., Brandt, J., Rao, V., Steinberg, M., Troncoso, J. C., & Rabins, P. V. (2004) · Neurology · doi:10.1212/01.wnl.0000133008.89613.82 · Cited by 66
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
Phan, S. V., Osae, S. P., Morgan, J. C., Inyang, M., & Fagan, S. C. (2019) · Drugs in R&D · doi:10.1007/s40268-019-0272-1 · Cited by 76
Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials
Mortby, M. E., Adler, L., Agüera-Ortíz, L., Bateman, D. R., Brodaty, H., Cantillon, M., Geda, Y. E., Ismail, Z., Lanctôt, K. L., Marshall, G. A., et al. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.06.016 · Cited by 69
Latent classes of neuropsychiatric symptoms in NACC controls and conversion to MCI or dementia
Leoutsakos, J., Forrester, S. N., Lyketsos, C., & Smith, G. S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150421 · Cited by 60
Self-citationPanza, F., Frisardi, V., Seripa, D., D’Onofrio, G., Santamato, A., Masullo, C., Logroscino, G., Solfrizzi, V., & Pilotto, A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.005 · Cited by 68
Huang, H., Kuo, L., Chen, Y.-S., Liang, J., Huang, H., Chiu, Y., Chen, S., Sun, Y., Hsu, W., & Shyu, Y. L. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.09.009 · Cited by 66
Psychiatric Symptoms in Adults With Down Syndrome and Alzheimer's Disease
Urv, T. K., Zigman, W. B., & Silverman, W. P. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.4.265 · Cited by 65
Roiger, T. C., Weidauer, L. A., & kern, B. (2015) · Journal of Athletic Training · doi:10.4085/1062-6050-49.3.83 · Cited by 67
Roberto, N., Portella, M. J., Marquié, M., Alegret, M., Hernández, I., Mauleón, A., Rosende‐Roca, M., Ruiz, C. A., Antonio, E. E., Gil, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83126-y · Cited by 66
Banning, L. C. P., Ramakers, I. H. G. B., Köhler, S., Bron, E. E., Verhey, F. R. J., Deyn, P. P. D., Claassen, J. A. H. R., Koek, H. L., Middelkoop, H. A. M., van der Flier, W. M., et al. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.01.012 · Cited by 65
Chung, J. K., Initiative, A. D. N., Plitman, E., Nakajima, S., Chow, T. W., Chakravarty, M. M., Caravaggio, F., Gerretsen, P., Brown, E. E., Iwata, Y., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142931 · Cited by 70
Specific psychological and behavioral symptoms of depression in patients with dementia
Prado‐Jean, A., Couratier, P., Druet‐Cabanac, M., Nubukpo, P., Bernard‐Bourzeix, L., Thomas, P., Dechamps, N., Videaud, H., DANTOINE, T. F., & Clément, J. P. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2468 · Cited by 74
Dam, D. V., Vermeiren, Y., Dekker, A. D., Naudé, P. J. W., & Deyn, P. P. D. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 68
Prevalence and clinical correlates of neuropsychiatric symptoms in dementia
Steffens, D. C., Maytan, M., Helms, M. J., & Plassman, B. L. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000611 · Cited by 65
Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias
Barton, C., Ketelle, R., Merrilees, J. J., & Miller, B. L. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0618-1 · Cited by 70
Misquitta, K., Dadar, M., Collins, D. L., Tartaglia, M. C., & Initiative, A. D. N. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102367 · Cited by 65
Ruths, S., Straand, J., Nygaard, H. A., Bjorvatn, B., & Pallesen, S. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52470.x · Cited by 64
The Economic Impact of Neuropsychiatric Symptoms in Alzheimer???s Disease
Murman, D. L., & Colenda, C. C. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523030-00004 · Cited by 64
Tissot, C., Therriault, J., Pascoal, T. A., Chamoun, M., Lussier, F. Z., Savard, M., Mathotaarachchi, S. S., Benedet, A. L., Thomas, E. M., Parsons, M., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12154 · Cited by 63
Chronic neurocognitive effects of critical illness
Hopkins, R. O., & Brett, S. J. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000166399.88635.a5 · Cited by 63
Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics
Peters, K. R., Rockwood, K. J., Black, S. E., Bouchard, R. W., Gauthier, S. G., Hogan, D. B., Kertesz, A., Loy-English, I., Beattie, B. L., Sadovnick, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000198255.84842.06 · Cited by 63
The course of neuropsychiatric symptoms in patients with dementia in Norwegian nursing homes
Bergh, S., Engedal, K., Røen, I., & Selbæk, G. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001177 · Cited by 63
van der Linde, R. M., Matthews, F. E., Dening, T., & Brayne, C. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4464 · Cited by 63
Sharpe, L., McDonald, S., Correia, H., Raue, P. J., Meade, T., Nicholas, M. K., & Areán, P. A. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1334-y · Cited by 63
Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia
Kerns, J. W., Winter, J. D., Winter, K. M., Kerns, C. C., & Etz, R. S. (2018) · The Gerontologist · doi:10.1093/geront/gnx042 · Cited by 62
Livingston, G., Barber, J., Marston, L., Stringer, A., Panca, M., Hunter, R., Cooper, C., Laybourne, A., La Frenais, F., Reeves, S., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30045-8 · Cited by 62
Yao, Z., Hu, B., Liang, C., Zhao, L., Jackson, M., & Initiative, T. A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048973 · Cited by 62
Chen, P., Guarino, P., Dysken, M. W., Pallaki, M., Asthana, S., Llorente, M. D., Love, S. B., Vertrees, J. E., Schellenberg, G. D., & Sano, M. C. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718783897 · Cited by 65
Fischer, C. E., Ismail, Z., Youakim, J. M., Creese, B., Kumar, S., Núñez, N. A., Darby, R. R., Vita, A. D., D’Antonio, F., de Lena, C., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190828 · Cited by 65
Self-citationAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
Lalonde, R., Fukuchi, K., & Strazielle, C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.011 · Cited by 66
Thorpe, J. M., Houtven, C. H. V., Sleath, B. L., & Thorpe, C. T. (2010) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2010.00276.x · Cited by 62
Hsu, W., Lane, H., & Lin, C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00091 · Cited by 63
Alexander, N., Alexander, D. C., Barkhof, F., & Denaxas, S. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01693-6 · Cited by 66
Risk of Suicide After Dementia Diagnosis
Alothman, D., Card, T. R., Lewis, S., Tyrrell, E. G., Fogarty, A., & Marshall, C. R. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3094 · Cited by 66
Gut microbiome alterations in preclinical Alzheimer’s disease
Jung, J. H., Kim, G., Byun, M. S., Lee, J. H., Yi, D., Park, H., & Lee, D. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278276 · Cited by 63
Ensemble deep learning for Alzheimer’s disease characterization and estimation
Tanveer, M., Goel, T., Sharma, R., Malik, A. K., Beheshti, I., Ser, J. D., Suganthan, P. N., & Lin, C. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00237-x · Cited by 67
The Dysexecutive Syndrome of Alzheimer's Disease: The GREFEX Study
Godefroy, O., Martinaud, O., Verny, M., Mosca, C., Lenoir, H., Bretault, E., Roussel, M., & GREFEX Study Group (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140585 · Cited by 61
Bradshaw, L. E., Goldberg, S. E., Lewis, S., Whittamore, K. H., Gladman, J. R. F., Jones, R. G., & Harwood, R. (2013) · Age and Ageing · doi:10.1093/ageing/aft074 · Cited by 59
Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease
Theleritis, C. G., Siarkos, K., Katirtzoglou, E. A., & Politis, A. M. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716678684 · Cited by 63
Electroconvulsive Therapy for Agitation and Aggression in Dementia: A Systematic Review
van den Berg, J. F., Kruithof, H. C., Kok, R., Verwijk, E., & Spaans, H. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.09.023 · Cited by 64
Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia
Van der Mussele, S., Le Bastard, N., Saerens, J., Somers, N., Mariën, P., Goeman, J., De Deyn, P. P., & Engelborghs, S. (2015) · Aging & Mental Health · doi:10.1080/13607863.2014.924900 · Cited by 60
von Gunten, A., Pocnet, C., & Rossier, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.004 · Cited by 64
Neurobiology of apathy in Alzheimer's disease
Guimarães, H. C., Lévy, R., Teixeira, A. L., Beato, R., & Caramelli, P. (2008) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2008000300035 · Cited by 60
Mortality in Elderly Dementia Patients Treated With Risperidone
Haupt, M., Cruz-Jentoft, A. J., & Jeste, D. V. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239796.21826.39 · Cited by 60
Mulin, E., Zeitzer, J. M., Friedman, L., Duff, F. L., Yesavage, J. A., Robert, P. H., & David, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101701 · Cited by 60
Goris, E. D., Ansel, K. N., & Schutte, D. L. (2016) · Journal of Advanced Nursing · doi:10.1111/jan.13026 · Cited by 60
Role of Sleep Disturbance in the Trajectory of Alzheimer’s Disease
Kang, D. W., Lee, C. U., & Lim, H. K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.2.89 · Cited by 61
Chen, C., Hu, Z., Jiang, Z., & Zhou, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.110 · Cited by 69
The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer’s Disease
Ni, H., Xu, M., Zhan, G., Fan, Y., Zhou, H., Jiang, H., Lu, W., Tan, L., Zhang, D., Yao, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180276 · Cited by 61
Depression in Alzheimer’s disease
STARKSTEIN, S. E., & Mizrahi, R. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.6.887 · Cited by 60
Ferreira, A. R., Dias, C. C., & Fernandes, L. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00072 · Cited by 55
Guercio, B. J., Donovan, N. J., Ward, A., Schultz, A., Lorius, N., Amariglio, R. E., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13060141 · Cited by 61
Grossberg, G. T., Pejović, V., Miller, M. L., & Graham, S. M. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000200013 · Cited by 59
Effects of Ginkgo Biloba Special Extract EGb 761® in Very Mild Cognitive Impairment (vMCI)
Grass‐Kapanke, B., Busmane, A., Lasmanis, A., Hoerr, R., & Kaschel, R. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.21007 · Cited by 59
Psychosis in Alzheimer’s Disease
Ballard, C. G., Kales, H. C., Lyketsos, C. G., Aarsland, D., Creese, B., Mills, R., Williams, H., & Sweet, R. A. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01074-y · Cited by 63
Self-citationGallagher, D., & Herrmann, N. (2014) · Drugs · doi:10.1007/s40265-014-0293-6 · Cited by 59
Characteristics and Mental Health of Hispanic Dementia Caregivers in New York City
Luchsinger, J. A., Tipiani, D., Torres-Patiño, G., Silver, S. A., Eimicke, J. P., Ramirez, M. M., Teresi, J. A., & Mittelman, M. S. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514568340 · Cited by 63
Beyond the “C” in MCI: Noncognitive Symptoms in Amnestic and Non-amnestic Mild Cognitive Impairment
Ellison, J. M., Harper, D. G., Berlow, Y., & Zeranski, L. (2008) · CNS Spectrums · doi:10.1017/s1092852900016175 · Cited by 59
Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases
Takada, M., Fujimoto, M., & Hosomi, K. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.16185 · Cited by 59
Drye, L. T., Martin, B. K., Frangakis, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., Schneider, L. S. S., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2565 · Cited by 58
Self-citationWatt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Thompson, Y. Y., Lai, Y., Treister, V., Tricco, A. C., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01607-7 · Cited by 67
Panza, F., D’Introno, A., Colacicco, A. M., Capurso, C. A., Parigi, A. D., Caselli, R. J., Frisardi, V., Scapicchio, P. L., Chiloiro, R., Scafato, E., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1111 · Cited by 62
Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction.
Aretouli, E., Tsilidis, K. K., & Brandt, J. (2012) · Neuropsychology · doi:10.1037/a0030481 · Cited by 62
Dysexecutive disorders and their diagnosis: A position paper
Godefroy, O., Martinaud, O., Narme, P., Joseph, P., Mosca, C., Lhommée, E., Meulemans, T., Czernecki, V., Bertola, C., Labauge, P. M., et al. (2018) · Cortex · doi:10.1016/j.cortex.2018.09.026 · Cited by 58
Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia
Banks, W. A., & Morley, J. E. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.4.m314 · Cited by 57
Jajodia, A., & Borders, A. (2011) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr035 · Cited by 59
Davydow, D. S., Zivin, K., Katon, W. J., Pontone, G. M., Chwastiak, L., Langa, K. M., & Iwashyna, T. J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2916-8 · Cited by 57
Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment
Munro, C. E., Donovan, N. J., Guercio, B. J., Wigman, S. E., Schultz, A. P., Amariglio, R. E., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150017 · Cited by 57
Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer's Disease
Hu, X., Meiberth, D. U., Newport, B., & Jessen, F. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150302154914 · Cited by 58
Depressive symptoms, vascular risk factors, and Alzheimer's disease
Luchsinger, J. A., Honig, L. S., Tang, M., & Devanand, D. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2006 · Cited by 60
Rivastigmine for Alzheimer’s disease
Desai, A. K., & Grossberg, G. T. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.5.563 · Cited by 63
Bertens, A. S., Moonen, J. E. F., de Waal, M. W. M., Foster‐Dingley, J. C., de Ruijter, W., Gussekloo, J., van der Mast, R. C., & de Craen, A. J. M. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4484 · Cited by 57
Costa, N., Wübker, A., Mauléon, A. D., Zwakhalen, S. M. G., Challis, D., Leino‐Kilpi, H., Hallberg, I. R., Stephan, A., Zabalegui, A., Saks, K., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.10.013 · Cited by 58
Temporal course of depressive symptoms during the development of Alzheimer disease
Wilson, R. S., Hoganson, G. M., Rajan, K. B., Barnes, L. L., de Leon, C. F. M., & Evans, D. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e620c5 · Cited by 57
Age-related changes in social behaviours in the 5xFAD mouse model of Alzheimer’s disease
Kosel, F., Muñoz, P., Yang, J., Wong, A. A., & Franklin, T. B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.029 · Cited by 57
Maladaptive Behaviors Related to Dementia Status in Adults With Down Syndrome
Urv, T. K., Zigman, W. B., & Silverman, W. P. (2008) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2008)113[73:mbrtds]2.0.co;2 · Cited by 56
Experience and Perspectives of Caregivers of Spouse with Mild Cognitive Impairment
Lu, Y.-F., & Haase, J. E. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929309 · Cited by 56
Kawai, N., Kawanishi, M., Kudomi, N., Maeda, Y., Yamamoto, Y., Nishiyama, Y., & Tamiya, T. (2013) · Brain Injury · doi:10.3109/02699052.2013.794963 · Cited by 54
Cognitive-Behavioral Therapy in Older Adults
Conti, E. C., Kraus-Schuman, C. A., & Stanley, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803457-6.00010-6 · Cited by 55
The positive aspects of caregiving in dementia: A scoping review and bibliometric analysis
Wang, J., Li, X., Liu, W., Yang, B., Zhao, Q., Lü, Y., & Xiao, M. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.985391 · Cited by 67
Spalletta, G., Caltagirone, C., Girardi, P., Gianni, W., Casini, A. R., & Palmer, K. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.11.018 · Cited by 55
Epidemiology, Assessment, and Treatment of Dementia
Nowrangi, M. A., Rao, V., & Lyketsos, C. G. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.004 · Cited by 58
Self-citationTrajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment
David, N. D., Lin, F. V., & Porsteinsson, A. P. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.06.001 · Cited by 60
Bories, C., Husson, Z., Guitton, M. J., & Koninck, Y. D. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3258-12.2013 · Cited by 53
Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias
Bronner, G., Aharon‐Peretz, J., & Hassin‐Baer, S. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63247-0.00017-1 · Cited by 56
Spiegel, R., Kalla, R., Mantokoudis, G., Maire, R., Mueller, H., Hoerr, R., & Ihl, R. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s157877 · Cited by 57
High Occurrence of Psychiatric Disorders and Suicidal Behavior Across Dementia Subtypes
Lai, A. X., Kaup, A. R., Yaffe, K. S., & Byers, A. L. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.08.012 · Cited by 55
Uncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia
Shaw, S. R., El-Omar, H., Roquet, D., Hodges, J. R., Piguet, O., Ahmed, R. M., Whitton, A. E., & Irish, M. (2021) · Brain · doi:10.1093/brain/awab032 · Cited by 61
Regan, B., & Varanelli, L. (2013) · International Psychogeriatrics · doi:10.1017/s104161021300152x · Cited by 60
Stephen Morris, A., Patel, N. V., Baio, G., Kelly, L., Lewis-Holmes, E., Omar, R., Katona, C., Cooper, C., & Livingston, G. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007382 · Cited by 54
Hidaka, S., Ikejima, C., Kodama, C., Nose, M., Yamashita, F., Sasaki, M., Kinoshita, T., Tanimukai, S., Mizukami, K., Takahashi, H., et al. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2715 · Cited by 55
Haibo, X., Shifu, X., Pin, N. T., Chen, C., Guorong, M., Xuejue, L., 卜时明, Wenli, F., Jun, L., Mingyuan, Z., et al. (2013) · Aging & Mental Health · doi:10.1080/13607863.2013.781116 · Cited by 54
Showraki, A., Murari, G., Ismail, Z., Barfett, J., Fornazzari, L., Muñoz, D. G., Schweizer, T. A., & Fischer, C. E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190365 · Cited by 56
LAM, L. C. W., Tam, C. W. C., Chiu, H. F. K., & Lui, V. W.-C. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1694 · Cited by 54
Meditation and cognitive ageing: the role of mindfulness meditation in building cognitive reserve.
Malinowski, P., & Shalamanova, L. (2017) · Journal of Cognitive Enhancement · doi:10.1007/s41465-017-0022-7 · Cited by 50
Wiels, W. A., Wittens, M. M. J., Zeeuws, D., Baeken, C., & Engelborghs, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707580 · Cited by 52
Pa, J., Goodson, W. H., Bloch, A., King, A. C., Yaffe, K. S., & Barnes, D. E. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13158 · Cited by 53
Metadata
- Authors
- Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S.
- Affiliations
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- Wake Forest University (US)
- University of Washington (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-09-25
- Volume
- 288
- Issue
- 12
- Pages
- 1475
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2088361570
- Cited by
- 2,049
- References
- 57
- Citations by year
- 2026: 57 · 2025: 94 · 2024: 105 · 2023: 99 · 2022: 98 · 2021: 117 · 2020: 115 · 2019: 104 · 2018: 109 · 2017: 101 · 2016: 98 · 2015: 92 · 2014: 93 · 2013: 97 · 2012: 98
- FWCI
- 24.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc085079-024, n01hc015103-009, 5r01mh056511-05, n01hc085086-022, n01hc035129-010)
- National Institute on Aging (R01 AG 11380, R01AG011380, 5R01 AG 15928-02, R01AG015928)
- National Heart, Lung, and Blood Institute (N01HC15103, N01 HC85086, N01-HC85079, N01HC35129)
- National Institute of Mental Health (R01 MH 56511)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neuropsychiatric symptoms, dementia, mild cognitive impairment, prevalence, Neuropsychiatric Inventory, depression, apathy, irritability, agitation, aberrant motor behavior, Alzheimer-type dementia, Cardiovascular Health Study, population-based study, symptom onset timing, aberrant behavior
- MeSH terms
- Aged, Aggression, Anxiety, Feeding and Eating Disorders, Behavioral Symptoms, Cognition Disorders, Cross-Sectional Studies, Delusions, Dementia, Depression, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Sleep Wake Disorders, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review